- Home
- GERN vs KLG Comparison
GERN vs KLG Comparison
Compare GERN & KLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- KLG
- Stock Information
- Founded
- GERN 1990
- KLG 2022
- Country
- GERN United States
- KLG United States
- Employees
- GERN N/A
- KLG N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- KLG Packaged Foods
- Sector
- GERN Health Care
- KLG Consumer Staples
- Exchange
- GERN Nasdaq
- KLG Nasdaq
- Market Cap
- GERN 1.5B
- KLG 1.6B
- IPO Year
- GERN 1996
- KLG N/A
- Fundamental
- Price
- GERN $2.57
- KLG $19.98
- Analyst Decision
- GERN Strong Buy
- KLG Sell
- Analyst Count
- GERN 11
- KLG 8
- Target Price
- GERN $6.82
- KLG $17.88
- AVG Volume (30 Days)
- GERN 12.4M
- KLG 1.4M
- Earning Date
- GERN 02-26-2025
- KLG 02-11-2025
- Dividend Yield
- GERN N/A
- KLG 3.31%
- EPS Growth
- GERN N/A
- KLG N/A
- EPS
- GERN N/A
- KLG 0.82
- Revenue
- GERN $29,480,000.00
- KLG $2,708,000,000.00
- Revenue This Year
- GERN $31,918.56
- KLG $0.92
- Revenue Next Year
- GERN $289.41
- KLG N/A
- P/E Ratio
- GERN N/A
- KLG $24.35
- Revenue Growth
- GERN 9199.68
- KLG N/A
- 52 Week Low
- GERN $1.64
- KLG $14.36
- 52 Week High
- GERN $5.34
- KLG $24.63
- Technical
- Relative Strength Index (RSI)
- GERN 31.98
- KLG 69.00
- Support Level
- GERN $2.49
- KLG $15.97
- Resistance Level
- GERN $2.84
- KLG $20.01
- Average True Range (ATR)
- GERN 0.15
- KLG 0.96
- MACD
- GERN -0.01
- KLG 0.42
- Stochastic Oscillator
- GERN 13.33
- KLG 78.07
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About KLG WK Kellogg Co
WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini-Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2023 base) from the US.